Lovastatin

CHEMBL503 Phase 4 已批准 Small molecule
Half-Life
2-3 hours
Bioavailability
Protein Binding
Molecular Weight
404.5 g/mol
LogP
4.3
Phase
4

A naturally occurring statin originally derived from fungus, used to lower LDL cholesterol and reduce the risk of cardiovascular events, and studied for potential anticancer and neuroprotective effects. It inhibits HMG-CoA reductase, the key enzyme in cholesterol synthesis.

分子量

404.5390 g/mol

LogP

4.30

TPSA

72.80 Ų

Lipinski 五规则

符合

治疗领域

药物分类

作用机制

First naturally derived statin; prodrug hydrolyzed to active beta-hydroxy acid inhibiting HMG-CoA reductase.

Pharmacokinetics (PK)

Half-Life 2-3 hours

Pharmacodynamics (PD)

机制

First naturally derived statin; prodrug hydrolyzed to active beta-hydroxy acid inhibiting HMG-CoA reductase.

二维结构

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21

InChI

InChI=1S/C24H36O5/c1-5-15(3)24(27)29-21-11-14(2)10-17-7-6-16(4)20(23(17)21)9-8-19-12-18(25)13-22(26)28-19/h6-7,10,14-16,18-21,23,25H,5,8-9,11-13H2,1-4H3/t14-,15-,16-,18+,19+,20-,21-,23-/m0/s1

Molecular Formula

C24H36O5

HBD / HBA

1 / 5

可旋转键数

7

重原子数

29

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

常见问题

A naturally occurring statin originally derived from fungus, used to lower LDL cholesterol and reduce the risk of cardiovascular events, and studied for potential anticancer and neuroprotective effects. It inhibits HMG-CoA reductase, the key enzyme in cholesterol synthesis.

First naturally derived statin; prodrug hydrolyzed to active beta-hydroxy acid inhibiting HMG-CoA reductase.

Key pharmacokinetic parameters for Lovastatin: Half-life: 2-3 hours.

Yes, Lovastatin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

Related Drugs

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL503. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 53232. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.